Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Lemonnier

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Immunological Reviews|July 1, 1985
HLA class I genes: from structure to expression, serology and functionB R Jordan, D Caillol, M Damotte, et al.
The Journal of Infectious Diseases|March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriersA Ureta-Vidal, C Pique, Z Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on systemF Ginhoux, S Turbant, D A Gross, et al.
International Journal of Cancer|February 1, 2000
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chainL Carmon, K M El-Shami, A Paz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapyL Mateo, J Gardner, Q Chen, et al.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
European Journal of Immunology|April 13, 2000
Role of Qa-1(b)-binding receptors in the specificity of developing NK cellsM Salcedo, F Colucci, P J Dyson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibodyF A Lemonnier, P P Le Bouteiller, D Olive, et al.
British Journal of Cancer|July 3, 2003
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouseA Scardino, P Correale, H Firat, et al.
European Journal of Immunology|May 6, 1999
Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responsesB Pérarnau, M F Saron, B Reina San Martin, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Immunological Reviews|July 1, 1985
HLA class I genes: from structure to expression, serology and functionB R Jordan, D Caillol, M Damotte, et al.
The Journal of Infectious Diseases|March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriersA Ureta-Vidal, C Pique, Z Garcia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on systemF Ginhoux, S Turbant, D A Gross, et al.
International Journal of Cancer|February 1, 2000
Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chainL Carmon, K M El-Shami, A Paz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
An HLA-A2 polyepitope vaccine for melanoma immunotherapyL Mateo, J Gardner, Q Chen, et al.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
European Journal of Immunology|April 13, 2000
Role of Qa-1(b)-binding receptors in the specificity of developing NK cellsM Salcedo, F Colucci, P J Dyson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibodyF A Lemonnier, P P Le Bouteiller, D Olive, et al.
British Journal of Cancer|July 3, 2003
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouseA Scardino, P Correale, H Firat, et al.
European Journal of Immunology|May 6, 1999
Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responsesB Pérarnau, M F Saron, B Reina San Martin, et al.
Pageof 8